NEWS AND PERSPECTIVES
Since it was first reported in the 1960s, methicillinresistant Staphylococcus aureus (MRSA) has been a major cause of a variety of infectious syndromes in patients exposed to the healthcare environment. 1 In Taiwan, MRSA was first documented in the early 1980s and increased rapidly in the 1990s. 1 The importance of antibiotic stewardship for CA-MRSA disease in Taiwan can be demonstrated in four different ways. Several previous community-based studies and the latest islandwide survey have assessed the extent of MRSA in the community, and have revealed a high prevalence of colonization with multidrug-resistant MRSA. 3, 6, 8 The second aspect concerns the relationship between nasal strains of PVL-positive MRSA and CA disease, evidence of which has been provided by antimicrobial drug susceptibility testing, SCCmec typing, exotoxin profiling, and PFGE typing. 6 Our recently published prospective observational study has disclosed that previous antibiotic use is associated with PVL-positive MRSA colonization. 10 Therefore, appropriate use of antimicrobial drugs might be a strategy for limiting the incidence of CA-MRSA disease in Taiwan. The third aspect is related to the novel molecular characteristics of ST59 CA-MRSA strains in Taiwan. Takano et al 7 have shown that the major PVL-positive CA-MRSA ST59 Taiwan strain possesses a tetracycline-resistance-conferring (tetK positive) penicillinase plasmid and a multidrug-resistance gene cluster (a possible composite transposon), which imply indirectly the high antibiotic selective pressure in our community. Finally, from the management point of view, most authorities recommend that the therapeutic strategy for CA-MRSA infections should be based on the severity and site of disease in areas with high prevalence of methicillin resistance, such as Taiwan. 1, 4 CA-MRSA infection is most often manifested in the skin and superficial soft tissue and responds well spontaneously or after incision and drainage, with or without susceptible antibiotic treatment. Thus, the use of glycopeptides or linezolid should be reserved for patients with invasive CA-MRSA infections or those that involve deep-seated areas of the body, to limit the impact of increasing antimicrobial resistance.
In the past, the rapid emergence of resistant bacteria in Taiwan has been spurred on by the ease of obtaining antibiotics from over-the-counter drug stores, as well as the widespread use of antimicrobial agents in animal husbandry. In 2001, government policy prohibited antibiotic use for acute respiratory tract infections without evidence of bacterial infection, which resulted in a decrease in the use of penicillins, cephalosporins and macrolides, and also reduced macrolide-resistant group A streptococci. 11 Thus, an effective strategy for antibiotic stewardship must be multifaceted and include education of physicians and patients about appropriate antimicrobial use, surveillance of antimicrobial resistance and use, and development of alternative treatment that circumvents the need for antimicrobial therapy. In addition, Schneider-Lindner et al 12 have reported recently
an association between receipt of antimicrobial agents and diagnosis of CA-MRSA in the United Kingdom, which is particularly strong for previous exposure to fluoroquinolones and macrolides. Further studies are warranted to elucidate the specific antimicrobial drugs that may cause selection pressures that favor the acquisition of antibiotic resistance in S. aureus in the community, to limit the spread of CA-MRSA in Taiwan.
